These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 17668159

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying disease.
    Fox RJ, Bethoux F, Goldman MD, Cohen JA.
    Cleve Clin J Med; 2006 Jan; 73(1):91-102. PubMed ID: 16444920
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Spotlight on alemtuzumab.
    Jones JL, Coles AJ.
    Int MS J; 2009 Sep; 16(3):77-81. PubMed ID: 19878629
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Considerations in the treatment of relapsing-remitting multiple sclerosis.
    Calabresi PA.
    Neurology; 2002 Apr 23; 58(8 Suppl 4):S10-22. PubMed ID: 11971122
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Spotlight on anti-CD25: daclizumab in MS.
    Schippling DS, Martin R.
    Int MS J; 2008 Sep 23; 15(3):94-8. PubMed ID: 18808743
    [Abstract] [Full Text] [Related]

  • 17. Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis.
    Zivadinov R, Dwyer MG, Hussein S, Carl E, Kennedy C, Andrews M, Hojnacki D, Heininen-Brown M, Willis L, Cherneva M, Bergsland N, Weinstock-Guttman B.
    Mult Scler; 2012 Aug 23; 18(8):1125-34. PubMed ID: 22194217
    [Abstract] [Full Text] [Related]

  • 18. The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews.
    Clerico M, Rivoiro C, Contessa G, Viglietti D, Durelli L.
    Clin Neurol Neurosurg; 2008 Nov 23; 110(9):878-85. PubMed ID: 18164542
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Aggressive multiple sclerosis. Definition and specific therapeutic indication].
    Edan G.
    Presse Med; 2004 Feb 14; 33(3):187-91; discussion 192. PubMed ID: 15029034
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.